Leishmania infantum devoid of mitochondrial peroxiredoxin are capable of surviving and proliferating in culture at wildtype levels
#Castro, H., #Romão, S., #Sousa, C., *Gadelha, F.R. & #Tomás, A.
#Instituto
de Biologia Molecular e Celular, Rua do Campo Alegre, 823, 4150 Porto,
Portugal and *Department of Biochemistry, Instituto de Biologia,
Universidade Estadual de Campinas, São Paulo.
Leishmania infantum is a trypanosomatid with relevance as human pathogen. Like in other aerobes, the Leishmania
mitochondrion constitutes an important source of reactive oxygen
species (ROS) and possibly also of reactive nitrogen intermediates
(RNI). Together these species can
cause irreversible damage to mitochondrial components, but they can
also regulate important cell signaling pathways. To
keep the concentration of ROI and RNI at harmless levels, the
mitochondrion is equipped with efficient antioxidant devices. In these
parasites, mitochondrial peroxiredoxin, LimTXNPx, presumably participates in ROI and RNI removal from this organelle. Using a DNA recombination strategy, L. infantum mutants lacking LimTXNPx were produced. The
growth curve of transformants did not significantly differ from
wild-type (WT) cells indicating that this enzyme does not control cell
proliferation. Endogenous H2O2
generation by inhibition of the mitochondrial respiratory chain by
antimycin A did not show any significant differences between LimTXNPx null mutants and WT cells. In face of these results we conclude that the physiological functions of LimTXNPx appear to be compensated by alternative antioxidants and/or repair mechanisms. Supported by: FCT (Portugal), FAPESP and CNPq
|